These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
568 related articles for article (PubMed ID: 38509409)
21. The Emerging Role of Noncoding RNA Regulation of the Ferroptosis in Cardiovascular Diseases. Zhang J; Liu X; Li X; Cai Y; Zhou Y; Wang Q; Xu Z; Xia P; Yang P; Jun L; Yu P; Shi A Oxid Med Cell Longev; 2022; 2022():3595745. PubMed ID: 36187333 [TBL] [Abstract][Full Text] [Related]
22. Broadening horizons: The role of ferroptosis in myocardial ischemia-reperfusion injury. Zhao K; Chen X; Bian Y; Zhou Z; Wei X; Zhang J Naunyn Schmiedebergs Arch Pharmacol; 2023 Oct; 396(10):2269-2286. PubMed ID: 37119287 [TBL] [Abstract][Full Text] [Related]
23. Targeting Ferroptosis to Treat Cardiovascular Diseases: A New Continent to Be Explored. Huang F; Yang R; Xiao Z; Xie Y; Lin X; Zhu P; Zhou P; Lu J; Zheng S Front Cell Dev Biol; 2021; 9():737971. PubMed ID: 34527678 [TBL] [Abstract][Full Text] [Related]
24. Roles of Ferroptosis in Cardiovascular Diseases. Guo Y; Zhang W; Zhou X; Zhao S; Wang J; Guo Y; Liao Y; Lu H; Liu J; Cai Y; Wu J; Shen M Front Cardiovasc Med; 2022; 9():911564. PubMed ID: 35677693 [TBL] [Abstract][Full Text] [Related]
25. Ferroptosis as a target for protection against cardiomyopathy. Fang X; Wang H; Han D; Xie E; Yang X; Wei J; Gu S; Gao F; Zhu N; Yin X; Cheng Q; Zhang P; Dai W; Chen J; Yang F; Yang HT; Linkermann A; Gu W; Min J; Wang F Proc Natl Acad Sci U S A; 2019 Feb; 116(7):2672-2680. PubMed ID: 30692261 [TBL] [Abstract][Full Text] [Related]
26. The Role of Ferroptosis in Cardiovascular Disease and Its Therapeutic Significance. Chen Z; Yan Y; Qi C; Liu J; Li L; Wang J Front Cardiovasc Med; 2021; 8():733229. PubMed ID: 34765653 [TBL] [Abstract][Full Text] [Related]
27. Targeting ferroptosis as a promising therapeutic strategy to treat cardiomyopathy. Sun H; Chen D; Xin W; Ren L; Li Q; Han X Front Pharmacol; 2023; 14():1146651. PubMed ID: 37138856 [TBL] [Abstract][Full Text] [Related]
28. Ironing out the details: ferroptosis and its relevance to diabetic cardiomyopathy. Gawargi FI; Mishra PK Am J Physiol Regul Integr Comp Physiol; 2023 Dec; 325(6):R665-R681. PubMed ID: 37746707 [TBL] [Abstract][Full Text] [Related]
29. Targeting ferroptosis in the maintenance of mitochondrial homeostasis in the realm of septic cardiomyopathy. Ye H; Hu H; Zhou X; Dong M; Ren J Curr Opin Pharmacol; 2024 Feb; 74():102430. PubMed ID: 38237386 [TBL] [Abstract][Full Text] [Related]
30. Ferroptosis Is a Potential Novel Diagnostic and Therapeutic Target for Patients With Cardiomyopathy. Zhai Z; Zou P; Liu F; Xia Z; Li J Front Cell Dev Biol; 2021; 9():649045. PubMed ID: 33869204 [TBL] [Abstract][Full Text] [Related]
32. Targeting ferroptosis and ferritinophagy: new targets for cardiovascular diseases. Luan Y; Yang Y; Luan Y; Liu H; Xing H; Pei J; Liu H; Qin B; Ren K J Zhejiang Univ Sci B; 2024 Jan; 25(1):1-22. PubMed ID: 38163663 [TBL] [Abstract][Full Text] [Related]
33. Mapping current research and identifying hotspots of ferroptosis in cardiovascular diseases. Teng T; Kong CY; Huang R; Ma ZG; Hu C; Zhang X; Hu M; Tang QZ Front Cardiovasc Med; 2022; 9():1046377. PubMed ID: 36407433 [TBL] [Abstract][Full Text] [Related]
34. Ferroptosis and Hydrogen Sulfide in Cardiovascular Disease. Wu ZF; Yan BJ; Luo W; Gui DD; Ren Z; Ma Y; Jiang ZS Curr Med Chem; 2023; 30(16):1848-1859. PubMed ID: 35786179 [TBL] [Abstract][Full Text] [Related]
35. Mechanisms of ferroptosis regulating oxidative stress and energy metabolism in myocardial ischemia-reperfusion injury and a novel perspective of natural plant active ingredients for its treatment. Zhang T; Deng W; Deng Y; Liu Y; Xiao S; Luo Y; Xiang W; He Q Biomed Pharmacother; 2023 Sep; 165():114706. PubMed ID: 37400352 [TBL] [Abstract][Full Text] [Related]
36. Loss of Cardiac Ferritin H Facilitates Cardiomyopathy via Slc7a11-Mediated Ferroptosis. Fang X; Cai Z; Wang H; Han D; Cheng Q; Zhang P; Gao F; Yu Y; Song Z; Wu Q; An P; Huang S; Pan J; Chen HZ; Chen J; Linkermann A; Min J; Wang F Circ Res; 2020 Jul; 127(4):486-501. PubMed ID: 32349646 [TBL] [Abstract][Full Text] [Related]
37. The Therapeutic Potential of Targeting Ferroptosis in the Treatment of Mitochondrial Cardiomyopathies and Heart Failure. Cantrell AC; Zeng H; Chen JX J Cardiovasc Pharmacol; 2024 Jan; 83(1):23-32. PubMed ID: 37816193 [TBL] [Abstract][Full Text] [Related]
38. Ferroptosis Involved in Cardiovascular Diseases: Mechanism Exploration of Ferroptosis' Role in Common Pathological Changes. Gao D; Hu L; Lv H; Lian L; Wang M; Fan X; Xie Y; Zhang J J Cardiovasc Pharmacol; 2024 Jan; 83(1):33-42. PubMed ID: 37890084 [TBL] [Abstract][Full Text] [Related]
39. Role of ferroptosis in the pathogenesis of heart disease. Fatima S; Zhou H; Chen Y; Liu Q Front Physiol; 2024; 15():1450656. PubMed ID: 39318361 [TBL] [Abstract][Full Text] [Related]
40. Deferasirox Targeting Ferroptosis Synergistically Ameliorates Myocardial Ischemia Reperfusion Injury in Conjunction With Cyclosporine A. Ishimaru K; Ikeda M; Miyamoto HD; Furusawa S; Abe K; Watanabe M; Kanamura T; Fujita S; Nishimura R; Toyohara T; Matsushima S; Koumura T; Yamada KI; Imai H; Tsutsui H; Ide T J Am Heart Assoc; 2024 Jan; 13(1):e031219. PubMed ID: 38158218 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]